Miami Cancer Institute to Host Inaugural Precision Oncology Symposium

Miami Cancer Institute, part of Baptist Health South Florida, will host its inaugural Precision Oncology Symposium February 3-4, 2023, according to conference organizers. The educational symposium, to be held in Coral Gables, Fla., at the Biltmore Hotel, will cover recent advances in the use of novel targeted agents and treatment combinations to treat cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcoma, brain tumors and other types of solid tumors. 

“We couldn’t be more excited to host the inaugural Miami Cancer Institute Precision Oncology Symposium here in South Florida,” says Manmeet Ahluwalia, M.D., M.B.A., the symposium’s director as well as Fernandez Family Foundation Endowed Chair in Cancer Research, Chief of Medical Oncology, Chief Scientific Officer, and Deputy Director of Miami Cancer Institute. “We expect to bring oncology leaders from around the country here to discuss the latest advances in solid-tumor therapies with physicians in the South Florida community.” 

Manmeet Ahluwalia, M.D., M.B.A., Fernandez Family Foundation Endowed Chair in Cancer Research, Chief of Medical Oncology, Chief Scientific Officer, and Deputy Director of Miami Cancer Institute

The Precision Oncology Symposium will  According to Dr. Ahluwalia, it will provide a unique opportunity to interact with key opinion leaders in the field, learn about the latest technologies, and connect with investigators who are leading cutting-edge clinical trials.

Given the increase in the discovery of oncogenic-driven tumors over the past two decades, targeted treatments with novel agents have positively transformed the outcomes in cancer patients, Dr. Ahluwalia says. But clinical decision making and management have become more complex as a result, and he says the symposium will provide opportunities for medical professionals to engage in thoughtful discussions with experts in these emerging fields in oncology.

“For the inaugural symposium, we’ve invited key opinion leaders and oncologists who are on the cutting edge of cancer treatment from the most prestigious organizations across the nation,” says Dr. Ahluwalia. “They will summarize the evolving therapeutic strategies, provide updates on new molecular and targeted treatments, discuss the rationale for new targeted diagnostic and therapeutic strategies, and review the role and timing of diagnostic tests, molecular profiling, and potential combinations of targeted therapy treatment options.”

Dr. Ahluwalia says the symposium should be of interest to oncologists, pathologists, radiation oncologists, palliative care staff, pharmacists, laboratory and other allied healthcare team members involved in the treatment of patients with solid tumor malignancies. He says that Baptist Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

“Baptist Health has been re-surveyed by the ACCME and awarded Commendation for six years as a provider of CME for physicians,” says Dr. Ahluwalia, adding that participants of the Precision Medicine Symposium will be able to claim CME credits by attending.